FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nils Wilking

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Sweden

Procedures

Concepts & Ideas

Physiology

Postmenopause

Co-author Network

Publications

TOP 3
Mariann Iiristo; Tom Wiklund; Nils Wilking; Jonas Bergh; Yvonne Brandberg
Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels.
Mia Bergenmar; Hemming Johansson; Nils Wilking
Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure.
Ulla Wilking; Bengt Jönsson; Nils Wilking; Jonas Bergh
Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nils Wilking (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Mariann Iiristo; Tom Wiklund; Nils Wilking; Jonas Bergh; Yvonne Brandberg
Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels.
Acta oncologica (Stockholm, Sweden) 2011;50(3):338-43.
2011: Mia Bergenmar; Hemming Johansson; Nils Wilking
Levels of knowledge and perceived understanding among participants in cancer clinical trials - factors related to the informed consent procedure.
Clinical trials (London, England) 2011;8(1):77-84.
2010: Ulla Wilking; Bengt Jönsson; Nils Wilking; Jonas Bergh
Trastuzumab use in breast cancer patients in the six Health Care Regions in Sweden.
Acta oncologica (Stockholm, Sweden) 2010;49(6):844-50.
2010: Nils Wilking; Bengt Jönsson; Wettermark Björn
[Utilization of antineoplastic agents in Sweden and Europe].
Läkartidningen 2010;107(16):1075-80.
2010: Nils Wilking
[Towards targeted treatment].
Läkartidningen 2010;107(16):1064.
2008: Mia Bergenmar; Clementine Molin; Nils Wilking; Yvonne Brandberg
Knowledge and understanding among cancer patients consenting to participate in clinical trials.
European journal of cancer (Oxford, England : 1990) 2008;44(17):2627-33.
2008: Lars L Gustafsson; Björn Wettermark; Mats Kalin; Seher Korkmaz; Marie E Persson; Henrik Almkvist; Paul Hjemdahl; Margaretha Julander; Krister Kristianson; Bo Ringertz; Gunilla Thörnwall Bergen-Dahl; Nils Wilking
[A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment].
Läkartidningen 2008;105(42):2917-22.
2008: Mathias Lidgren; Nils Wilking; Bengt Jönsson; Clas Rehnberg
Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1018-28.
2007: Mathias Lidgren; Nils Wilking; Bengt Jönsson; Clas Rehnberg
Health related quality of life in different states of breast cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2007;16(6):1073-81.
2007: Jonas Lundkvist; Nils Wilking; Stig Holmberg; Linus Jönsson
Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2-3 years treatment with tamoxifen in Sweden.
Breast cancer research and treatment 2007;102(3):289-99.
2007: Nils Wilking; Elisabet Lidbrink; Tom Wiklund; Bjørn Erikstein; Henrik Lindman; Per-Uno Malmstrom; Pirkko Kellokumpu-Lehtinen; Nils-Olof Bengtsson; G Söderlund; Gun Anker; Erik Wist; S Ottosson; E Salminen; P Ljungman; Harald Holte; J Nilsson; Carl Blomqvist; Jonas Bergh
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):694-700.
2007: Mathias Lidgren; Nils Wilking; Bengt Jönsson
Cost of breast cancer in Sweden in 2002.
The European journal of health economics : HEPAC : health economics in prevention and care 2007;8(1):5-15.
2007: Mathias Lidgren; Nils Wilking; Bengt Jönsson; Clas Rehnberg
Resource use and costs associated with different states of breast cancer.
International journal of technology assessment in health care 2007;23(2):223-31.
2007: E Isaksson Friman; M Mahlman; Bo Nilsson; Lambert Skoog; Lars Löfgren; Nils Wilking; Eva von Schoultz
Hormone therapy and estrogen receptor expression in breast cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(2):194-8.
2006: Nils Wilking; Bengt Jönsson; Christer Svedman
[Do Norwegian cancer patients receive the care they deserve?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2006;126(21):2828-9.
2006: Mervi Laakso; Minna Tanner; Jonas Nilsson; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Bergh; Jorma Isola
Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4185-91.
2006: Minna Tanner; Jorma Isola; Tom Wiklund; Bjørn Erikstein; Pirkko Kellokumpu-Lehtinen; Per Malmström; Nils Wilking; Jonas Nilsson; Jonas Bergh
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2428-36.
2004: P Byström; Jan-Erik Frödin; Ake Berglund; Nils Wilking; B Glimelius
Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(2):171-5.
2004: Lars Löfgren; Birgitta Wallberg; Nils Wilking; Tommy Fornander; Lars Erik Rutqvist; Kjell Carlström; Bo von Schoultz; Eva von Schoultz
Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids.
Medical oncology (Northwood, London, England) 2004;21(4):309-18.
2003: Yvonne Brandberg; Helena Michelson; Bo Nilsson; Christina Bolund; Bjørn Erikstein; Paivi Hietanen; Stein Kaasa; Jonas Nilsson; Tom Wiklund; Nils Wilking; Jonas Bergh
Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3659-64.
2003: Birgitta Wallberg; Helena Michelson; Marianne Nystedt; Christina Bolund; Lesley Degner; Nils Wilking
The meaning of breast cancer.
Acta oncologica (Stockholm, Sweden) 2003;42(1):30-5.
2000: Jonas Bergh; Tom Wiklund; Bjørn Erikstein; Elisabet Lidbrink; Henrik Lindman; Per Malmström; Pirkko Kellokumpu-Lehtinen; Nils-Olof Bengtsson; G Söderlund; Gun Anker; Erik Wist; S Ottosson; E Salminen; P Ljungman; Harald Holte; J Nilsson; Carl Blomqvist; Nils Wilking
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
Lancet 2000;356(9239):1384-91.
2000: T Fokstuen; Nils Wilking; Lars Erik Rutqvist; J Wolke; Anette Liedberg; T Signomklao; Jan-Olof Fernberg
Radiation therapy in the management of brain metastases from breast cancer.
Breast cancer research and treatment 2000;62(3):211-6.
2000: S Kvinnsland; Gun Anker; LY Dirix; Jacques Bonneterre; A M Prove; Nils Wilking; Jean-Pierre Lobelle; O Mariani; E di Salle; Anna Polli; Giorgio Massimini
High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.
European journal of cancer (Oxford, England : 1990) 2000;36(8):976-82.
2000: Birgitta Wallberg; Helena Michelson; Marianne Nystedt; Christina Bolund; L F Degner; Nils Wilking
Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2000;39(4):467-76.
1999: Erika Isaksson; Lena Sahlin; Gunnar Söderqvist; Eva von Schoultz; Britt Masironi; M Wickman; Nils Wilking; Bo von Schoultz; Lambert Skoog
Expression of sex steroid receptors and IGF-1 mRNA in breast tissue--effects of hormonal treatment.
The Journal of steroid biochemistry and molecular biology 1999;70(4-6):257-62.
1999: AM Billgren; Lars Erik Rutqvist; E Tani; Nils Wilking; Tommy Fornander; Lambert Skoog
Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survival.
Acta oncologica (Stockholm, Sweden) 1999;38(5):597-601.
1999: Henrik Lindman; Tom Wiklund; Harald Holte; P Ljungman; Carl Blomqvist; Gunnar Kvalheim; M Bengtsson; Mattias Höglund; Nils Wilking; Jonas Bergh
FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study Group.
Acta oncologica (Stockholm, Sweden) 1999;38(2):239-45.
1999: Erika Isaksson; J Mark Cline; Lambert Skoog; Gunnar Söderqvist; Nils Wilking; Eva von Schoultz; Bo von Schoultz
p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically postmenopausal cynomolgus macaques.
Breast cancer research and treatment 1999;53(1):61-7.
1998: Nils Wilking
Chemotherapy in the elderly.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(5):412-7.
1998: P Ljungman; Bo Björkstrand; Tommy Fornander; Mattias Höglund; Gunnar Juliusson; Henrik Lindman; A Malmström; S Rotstein; Martin Söderberg; Nils Wilking; Kenneth Villman; J Bergh
High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer.
Bone marrow transplantation 1998;22(5):445-8.
1998: Jonas Bergh; Tom Wiklund; Bjørn Erikstein; Tommy Fornander; Nils-Olof Bengtsson; Per Malmström; Pirkko Kellokumpu-Lehtinen; Gun Anker; H Bennmarker; Nils Wilking
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(4):403-11.
1997: Nils Wilking; Erika Isaksson; Eva von Schoultz
Tamoxifen and secondary tumours. An update.
Drug safety : an international journal of medical toxicology and drug experience 1997;16(2):104-17.
1995: Lars Erik Rutqvist; H Johansson; T Signomklao; U Johansson; Tommy Fornander; Nils Wilking
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.
Journal of the National Cancer Institute 1995;87(9):645-51.
1995: Björn Cedermark; H Johansson; Lars Erik Rutqvist; Nils Wilking
The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group.
Cancer 1995;75(9):2269-75.
1995: P Ljungman; B Björkstrand; G Gahrton; J Nordenström; A Shanwell; U Glas; S Rotstein; L E Rutqvist; Nils Wilking
[High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support].
Läkartidningen 1995;92(9):849, 851-3.
1995: Eva von Schoultz; H Johansson; Nils Wilking; Lars Erik Rutqvist
Influence of prior and subsequent pregnancy on breast cancer prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(2):430-4.
1995: L Iselius; C Larsson; A Lindblom; K Sandelin; Marie Wickman; Nils Wilking
[The first breast cancer gene isolated. Safer risk assessment for affected families].
Läkartidningen 1995;92(4):269-73, 275.
1994: Eva von Schoultz; Nils Wilking; Lars Erik Rutqvist; T Theve; Bo von Schoultz
[Estrogen therapy. Is breast cancer a contraindication to hormonal substitution therapy?].
Läkartidningen 1994;91(13):1302-6.
1994: Gunnar Söderqvist; H Olsson; Nils Wilking; Bo von Schoultz; Kjell Carlström
Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
The Journal of steroid biochemistry and molecular biology 1994;48(2-3):221-4.
1994: Torbjörn Holm; Björn Cedermark; T Häggmark; Nils Wilking
[Local recurrence after rectal cancer surgery. A surgical and oncological challenge].
Läkartidningen 1994;91(4):232-5.
1994: U Nylén; Erik Kock; Ingmar Lax; Göran Lundell; E af Trampe; Nils Wilking
Standardized precision radiotherapy in choroidal metastases.
Acta oncologica (Stockholm, Sweden) 1994;33(1):65-8.
1993: Anders F Mattsson; B I Rudén; Per Hall; Nils Wilking; Lars Erik Rutqvist
Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease.
Journal of the National Cancer Institute 1993;85(20):1679-85.
1993: L Boman; H Björvell; Björn Cedermark; N O Theve; Nils Wilking
Effects of early discharge from hospital after surgery for primary breast cancer.
The European journal of surgery = Acta chirurgica 1993;159(2):67-73.
1993: Tommy Fornander; Lars Erik Rutqvist; Nils Wilking; K Carlström; B von Schoultz
Oestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(4):497-500.
1993: S Rosenqvist; G Berglund; C Bolund; Tommy Fornander; Lars Erik Rutqvist; Lambert Skoog; Nils Wilking
Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(9):1325-6.
1992: L Pallis; Nils Wilking; B Cedermark; L E Rutqvist; L Skoog
Receptors for estrogen and progesterone in breast carcinoma in situ.
Anticancer research 1992;12(6B):2113-5.
1992: L Pallis; L Skoog; Ursula G Falkmer; Nils Wilking; L E Rutquist; Gert Auer; B Cedermark
The DNA profile of breast cancer in situ.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1992;18(2):108-11.
1992: Lars Erik Rutqvist; Björn Cedermark; U Glas; H Johansson; S Rotstein; Lambert Skoog; A Somell; T Theve; Nils Wilking; J Askergren
Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Stockholm Breast Cancer Study Group.
Acta oncologica (Stockholm, Sweden) 1992;31(2):265-70.
1992: Nils Wilking; Lars Erik Rutqvist; J Carstensen; A Mattsson; Lambert Skoog
Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group.
Acta oncologica (Stockholm, Sweden) 1992;31(1):29-35.
1991: Tommy Fornander; Lars Erik Rutqvist; Björn Cedermark; U Glas; A Mattsson; Lambert Skoog; A Somell; T Theve; Nils Wilking; J Askergren
Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1740-8.
1991: Lars Erik Rutqvist; Björn Cedermark; U Glas; A Mattsson; Lambert Skoog; A Somell; T Theve; Nils Wilking; J Askergren; M L Hjalmar
Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.
Journal of the National Cancer Institute 1991;83(18):1299-306.
1990: Lars Erik Rutqvist; Björn Cedermark; U Glas; H Johansson; S Rotstein; Lambert Skoog; A Somell; T Theve; Nils Wilking; J Askergren
Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer.
Cancer 1990;66(1):89-96.
1990: Eva von Schoultz; M Bixo; T Bäckström; H Silfvenius; Nils Wilking; Roger Henriksson
Sex steroids in human brain tumors and breast cancer.
Cancer 1990;65(4):949-52.
1989: Tommy Fornander; Lars Erik Rutqvist; Björn Cedermark; U Glas; A Mattsson; C Silfverswärd; Lambert Skoog; A Somell; T Theve; Nils Wilking
Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.
Lancet 1989;1(8630):117-20.
1988: Nils Wilking; S Rotstein; J Bergh
[New discoveries in breast cancer--prevention, diagnosis and endocrine therapy].
Läkartidningen 1988;85(35):2735-6.
1988: Nils Wilking; Lars Erik Rutqvist; T Theve
[LHRH analogs--a new treatment in hormone-dependent tumors].
Läkartidningen 1988;85(8):620-3.
1986: Kjell Carlström; Ake Pousette; G Rannevik; H Sköldefors; N O Theve; Nils Wilking
Endocrine treatment of breast cancer: effects upon intratumoral estrone sulfate metabolism and peripheral steroid levels.
Breast cancer research and treatment 1986;7 Suppl():S107-9.
1984: Nils Wilking; K Carlström; S A Gustafsson; L Karnström; B von Schoultz
Pregnancy-associated glycoprotein (alpha 2-PAG)--a possible marker in breast cancer?
International journal of cancer. Journal international du cancer 1984;34(4):479-81.
1984: Nils Wilking; Kjell Carlström; H Sköldefors; N O Theve
Estradiol formation and estrogen receptors in breast tumor tissue: effects of tamoxifen on estrogen interconversions in breast tumor homogenate in vitro.
Breast cancer research and treatment 1984;4(2):149-51.
1984: Ake Pousette; Lars-Erik Appelgren; Kjell Carlström; H Sköldefors; Nils Wilking; N O Theve
Purification and characterization of an estradiol-17 beta binding macromolecule in rat pancreas.
Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry 1984;38(5):407-14.
1984: Kjell Carlström; A Döberl; A Pousette; G Rannevik; Nils Wilking
Inhibition of steroid sulfatase activity by danazol.
Acta obstetricia et gynecologica Scandinavica. Supplement 1984;123():107-11.
1983: Nils Wilking; Lars-Erik Appelgren; K Carlström; Arne Wallgren; T Theve
[Chemical adrenalectomy--a new alternative in the treatment of advanced breast cancer].
Läkartidningen 1983;80(26-27):2644-5.
1983: H Sköldefors; R Fernstad; Nils Wilking
External biliary bypass. Report of a simple technique.
Acta chirurgica Scandinavica 1983;149(2):213-4.
1982: Ake Pousette; Kjell Carlström; H Sköldefors; Nils Wilking; N O Theve
Purification and partial characterization of a 17 beta-estradiol-binding macromolecule in the human pancreas.
Cancer research 1982;42(2):633-7.
1982: Nils Wilking; Kjell Carlström; H Sköldefors; N O Theve; Arne Wallgren
Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
Acta chirurgica Scandinavica 1982;148(4):345-9.
1980: Nils Wilking; Kjell Carlström; S A Gustafsson; H Sköldefors; O Tollbom
Oestrogen receptors and metabolism of oestrone sulphate in human mammary carcinoma.
European journal of cancer 1980;16(10):1339-44.